CNR1 and steatosis: According to Maccarrone et al. [24], CB1 and CB2 seemingly act in opposite directions in the liver: CB1 promotes fibrogenesis and steatosis, whereas CB2 is generally believed to mediate beneficial effects of endocannabinoids and prevents liver dysfunction.